***  For details on how to be removed from this list visit the  ***
***          CCP4 home page http://www.ccp4.ac.uk         ***



Hi Harry

The results you get are obviously going to be highly sample-dependent,
so it's important when choosing your sample a) to have a fully
representative sample, b) not to limit the sample unnecessarily and end
up with a sample which is too small to give statistically significant
results, and c) most importantly to choose only the most accurately
determined structures (R < .05, & exclude disordered, structures with
errors, polymers, powders & organometallics) to be in your sample
(though necessarily this conflicts with the 2nd requirement).  Including
inaccurate structures in the sample will inevitably increase the
dispersion of values, and torsion angles are particularly sensitive to
co-ordinate errors.  For info, I'm using the latest CSD release (5.27
with Jan & May '06 updates).

So using the same O-methyl ester search pattern as you did & using the
above quality criteria I get:

N = 317 (0 outliers excluded)
Range = 170.2 - 189.0
Mean = 180.0
SE of mean = 0.2
Sample SD = 3.4

For the N-methyl amides I only got 15 observations so I didn't bother to
do the stats.

The methyl esters and amides you have chosen are not really
representative, for one thing the -O-Me group is often disordered, or at
least has a high B factor and is often difficult to locate accurately,
which would tend to undermine precise determination of the torsion
angle.  Hence I chose the search pattern XC(H)(R)C(=O)OC(H)(R)R and the
corresponding secondary amide (X=any, R=C or H), and also specified that
the ester/amide group is acyclic to avoid any bias due to ring
constraints.  This includes the previous pattern as a subset, as well as
the large set of peptides so we shouldn't be short of samples for the
amide group!

So now for esters & still using the same exclusion criteria I get:

N = 5124 (1 outlier excluded)
Range = 160.8 - 200.2
Mean = 180.0
SE of mean = 0.1
Sample SD = 4.7

and for amides:

N = 860 (0 outliers excluded)
Range = 157.4 - 200.5
Mean = 179.2
SE of mean = 0.2
Sample SD = 6.0

The ranges for ester & amide are about the same, however using the range
as a measure of dispersion is not reliable due to sensitivity to
outliers.  The dispersion as measured by the sample SD, whose values I
reported previously, is clearly lower for esters than for amides -
admittedly this does seem to run contrary to chemical intuition but the
evidence of the data seems to be incontrovertible.

As I said the key here is to use as big a sample as possible of the
highest quality data while still being representative.

Regards

-- Ian

> -----Original Message-----
> From: Harry M. Greenblatt [mailto:[EMAIL PROTECTED] 
> Sent: Sunday, July 16, 2006 12:56 PM
> To: Ian Tickle
> Subject: ester vs peptide planarity
> 
> BS"D
> 
> Dear Ian,
> 
> 
> 
>       Hi, sorry but this theory doesn't accord with observation: for
>       non-conjugated acyclic esters in the CSD the RMSD of 
> the C-O torsion
>       about the mean (= 0) is ~ 4.7 deg; for non-conjugated 
> acyclic primary
>       amides it's well known that the RMSD of the C-N torsion 
> is ~ 6.0 deg
>       (mean = -1.0), so on average the ester is actually 
> slightly more planar
>       than the amide.  I know this because this is how we 
> obtain torsion
>       weights for ligand dictionaries (not perfect I know but 
> better than
>       nothing!).
> 
> 
> 
> 
>  Pursuant to my earlier e-mail to the BB, I did a search in 
> the CSD on two related structures:
> 
> R-CH2-CO-O-CH3  and R-CH2-CO-NH-CH3
> 
> The results are in keeping with an ester having less double 
> bond character, although the "study" is somewhat flawed by 
> the imbalance in sample sizes.
> 
> **Ester case**
> --------------------
> 
> 839 observations,
> 
> Min. 152.6
> Max.  -100.55
> Range  106.8
> Mean 179.9
> 
> Taking out the 2 most obvious outliers (from the same 
> structure, as a matter of fact)
> 
> 837 observations,
> 
> Min.  168.
> Max.  -163.6
> Range  28.4
> Mean  -179.9
> 
> //////////////////////////////////////////////////////////////
> ////////////////////////////////////
> **Amide case**
> ----------------------
> 
> 78 observations
> 
> Min.  169.7
> Max.  -173.9
> Range  16.3
> Mean  178.8
> 
> Thus, the range of values in the case of the esters is much 
> larger than that of the amides for the above case, consistent 
> with less double bond character.
> 
> Harry
> 
> --------------------------------------------------------------
> -----------
> 
> Harry M. Greenblatt
> 
> Staff Scientist
> 
> Dept of Structural Biology           [EMAIL PROTECTED]
> 
> Weizmann Institute of Science        Phone:  972-8-934-3625
> 
> Rehovot, 76100                       Facsimile:   972-8-934-4159
> 
> Israel 
> 
> 
> 
> 

Disclaimer

This communication is confidential and may contain privileged information 
intended solely for the named addressee(s). It may not be used or disclosed 
except for the purpose for which it has been sent. If you are not the intended 
recipient you must not review, use, disclose, copy, distribute or take any 
action in reliance upon it. If you have received this communication in error, 
please notify Astex Therapeutics Ltd by emailing [EMAIL PROTECTED] and destroy 
all copies of the message and any attached documents. 



Astex Therapeutics Ltd monitors, controls and protects all its messaging 
traffic in compliance with its corporate email policy. The Company accepts no 
liability or responsibility for any onward transmission or use of emails and 
attachments having left the Astex Therapeutics domain.  Unless expressly 
stated, opinions in this message are those of the individual sender and not of 
Astex Therapeutics Ltd. The recipient should check this email and any 
attachments for the presence of computer viruses. Astex Therapeutics Ltd 
accepts no liability for damage caused by any virus transmitted by this email. 
E-mail is susceptible to data corruption, interception, unauthorized amendment, 
and tampering, Astex Therapeutics Ltd only send and receive e-mails on the 
basis that the Company is not liable for any such alteration or any 
consequences thereof.



Reply via email to